News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Huang Andong
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 191,113 options to buy
@ $0.24, valued at
$45.9k
|
|
| 03/31/2023 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 41,065 options to buy
@ $1.05, valued at
$43.1k
|
|
| 10/07/2022 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 38,399 options to buy
@ $1.25, valued at
$48k
|
|
| 03/24/2022 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 21,878 options to buy
@ $1.92, valued at
$42k
|
|
| 10/07/2021 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 22,950 options to buy
@ $2.12, valued at
$48.7k
|
|
| 03/26/2021 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 20,873 options to buy
@ $2.27, valued at
$47.4k
|
|
| 10/05/2020 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 77,805 options to buy
@ $0.7052, valued at
$54.9k
|
|
| 07/21/2020 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.58, valued at
$197.5k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.35, valued at
$33.8k
|
|
| 06/23/2020 |
3
| Huang Andong (Director) has filed a Form 3 on Outlook Therapeutics, Inc. |
|
|